P1057 / Safety & Immunogenicity of Cold Adapted Influenza Vaccine In HIV-Infected Child

P1057 was a Phase I/II, open label study of cold-adapted live attenuated influenza vaccine (FluMist™) compared to inactivated influenza vaccine (IAIV, Fluzone®).  The study was designed to compare the safety and immunogenicity of FluMistTM with IAIV among HIV-infected children and adolescents as well as determine the prevalence and duration of viral shedding of FluMistTM in HIV-infected vaccinees.